why choose us

First received: March 31, 2023

Clinical Trial: A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

Study Status: Completed

Recruit Status: RECRUITING

Condition: Narcolepsy Type 1

Study Type: INTERVENTIONAL


Official Title: A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions

Brief Summary: The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 and type 2 narcolepsy from previous parent studies, TAK-861-2001 (NCT05687903) and TAK-861-2002 (NCT05687916).

Read more